September #84 : Clit Club - by Emily Bass

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

This Face has a Message for the World

Lines Composed in a Looking Glass

The Problem with Protease

Lipo: The Latest

Parent Trap

What's Life Worth?

ADA R.I.P.?

Wind Beneath Their Wings

Fuzzy Math:

Double Deal:

Getting Snippy

Creature Features

Clit Club

Con:

Safe Sucks:

Our Daily Med

Thymouse?

Run Interference

Look, Ma, No KS!

Warts Up, Doc?

Thai Clip:

Only Connect:

False Alarm:

Tribute: Linda Grinberg

Bayou Blues

Milestones:

Heroes

Mailbox

Back to Basics

Publisher's Letter



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

September 2002

Clit Club

by Emily Bass

It starred research doctors, not Hollywood divas, but May's Microbicides 2002 conference in Antwerp, Belgium, nevertheless served up some hilarious vagina monologues. The global gabfest on HIV-blocking gels and creams featured one scientist who pontificated about the physics of vaginal fluids, then blushed beet red at the mention of female orgasm. Another could refer to arousal only as "the good circumstances for sex."

Fortunately, most speakers left their squeamishness at home. A Texas researcher presented a sobering study of the attitudes of U.S. health-care providers who work with teens. They said they'd be unlikely to counsel girls to use microbicides because their clients have such a hard time taking the condom message to heart -- strange reasoning, since that's precisely why a noncondom option would be so helpful! More encouraging, Britain's Julie Pickering found that facing an HIV test wasn't a serious barrier to women's enrollment in a microbicide trial. This kind of finding -- that women can and will join trials -- is useful ammo against science-world skepticism about whether women in developing countries are willing to get tested for HIV and able to give informed consent and use microbicides correctly.

Lots of chatter could be heard on how to spread the word that the ubiquitous nonoxynol-9 spermicide actually expedites HIV transmission.

Overall, participants shared the sense that the decade-long fight to bring effective microbicides to market may have finally turned a corner. Next year marks the launch of two massive Phase III trials that together will enroll more than 17,000 women. And the conference was the coming-out party for the new International Partnership for Microbicides, an independent foundation that will dump resources and clout behind microbicide research and access.




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.